ocular diseases

Otsuka, Shape Ink Potential $1.5B Deal to Develop Eye AAV Gene Therapies
BioSpace
Fri, 09/8/23 - 10:11 am
Otsuka
Shape Therapeutics
gene therapy
AAV gene therapy
RNA editing
ocular diseases